TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 71 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $219,000 | -16.4% | 6,048 | 0.0% | 0.00% | – |
| Q1 2022 | $262,000 | +4.4% | 6,048 | +20.8% | 0.00% | – |
| Q4 2021 | $251,000 | -12.5% | 5,005 | +11.0% | 0.00% | – |
| Q3 2021 | $287,000 | +29.3% | 4,511 | +46.4% | 0.00% | – |
| Q2 2021 | $222,000 | -78.5% | 3,082 | -70.6% | 0.00% | -100.0% |
| Q3 2018 | $1,032,000 | – | 10,495 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ISZO CAPITAL MANAGEMENT LP | 582,409 | $90,011,000 | 60.33% |
| GUARDIAN POINT CAPITAL, LP | 70,000 | $10,819,000 | 10.19% |
| Think Investments LP | 186,373 | $28,804,000 | 8.16% |
| Greywolf Capital Management LP | 277,936 | $42,955,000 | 7.45% |
| Valentine Capital Asset Management, Inc. | 28,431 | $4,394,000 | 4.91% |
| FORT, L.P. | 63,675 | $9,841,000 | 4.69% |
| MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC | 527,266 | $81,489,000 | 3.63% |
| RPG Investment Advisory, LLC | 60,910 | $9,413,000 | 3.52% |
| Kerrisdale Advisers, LLC | 81,996 | $12,672,000 | 3.24% |
| Strategic Global Advisors, LLC | 48,154 | $7,442,000 | 3.17% |